EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report

Giovanni Mori iD, Martina Gottardi, Monica Guffanti, Antonella Castagna, Massimiliano Lanzafame

JAC-Antimicrobial Resistance · 05.03.2024 · 6 (2)

DOI: 10.1093/jacamr/dlae042 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 12.03.2024. Verfasst von Giovanni Mori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Ospedale Santa Chiara, Trento, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Unit of Infectious Diseases, Ospedale Santa Chiara, Trento, Italy.
  • Università Vita-Salute San Raffaele, Milano, Italy.
  • Unit of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy.

ORCID-Profile: Giovanni Mori

Zitieren

APA

Mori, G., Gottardi, M., Guffanti, M., Castagna, A., & Lanzafame, M. (2024). Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report. JAC-Antimicrobial Resistance, 6(2). https://doi.org/10.1093/jacamr/dlae042

Vancouver

Mori G, Gottardi M, Guffanti M, Castagna A, Lanzafame M. Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report. JAC-Antimicrobial Resistance. 2024;6(2). doi:10.1093/jacamr/dlae042

BibTeX
@article{Mori2024,
  author = {Mori, Giovanni and Gottardi, Martina and Guffanti, Monica and Castagna, Antonella and Lanzafame, Massimiliano},
  title = {Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/jacamr/dlae042}
}
Kostenlos starten →